Page Changed: Inhaled Insulin: Afrezza
Text Added:
A review of Afrezza written by Gary Scheiner, a Certified Diabetes Educator whose book I have often recommended, came out in May of 2017 and may be helpful to people considering trying this insulin. I trust Scheiner a lot more than I do random people tweeting, who may or may not be on the payroll of the company making this stuff. You can read his review in his newsletter, HERE. Unfortunately, there is still no one with this kind of preexisting credibility in the online diabetes community reporting on their use of Afrezza for Type 2 Diabetes. This may simply be because doctors are so resistant to prescribing fast acting insulin to people with Type 2 diabetes.
Thursday, May 25, 2017
Tuesday, May 16, 2017
FDA Puts Warning of Doubled Risk of Amputation on Invokana Label
Page changed: SGLT2 Inhibitors, Farxiga, Invokana, Jardiance.Dangerous New Drugs
Note: "Questionable" has been changed to "Dangerous in this page title.
Text Added:
Note: "Questionable" has been changed to "Dangerous in this page title.
Text Added:
Doubled Risk of Lower Limb Amputations
On May 16, 2017 the FDA ordered that a black box warning be added to the prescribing information for Invokana saying that it doubled the risk of experiencing an amputation. You can read the report about this very important warning in this Medscape news bulletin.
Subscribe to:
Posts (Atom)
